Citation Impact

Citing Papers

Translocator Protein/Peripheral Benzodiazepine Receptor Is Not Required for Steroid Hormone Biosynthesis
2013
Biotransformations of Steroids
1988
Metal-Substituted Protein MRI Contrast Agents Engineered for Enhanced Relaxivity and Ligand Sensitivity
2010 StandoutNobel
Menopause and Heart Disease
1990
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
2003 StandoutNature
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 StandoutNobel
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Reflections on sterol sidechain cleavage process catalyzed by cytochrome P450scc
2001
Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
1997
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Menopause and Risk Factors for Coronary Heart Disease
1989
Differential induction of peroxisomal and microsomal fatty‐acid‐oxidising enzymes by peroxisome proliferators in rat liver and kidney
1989
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Engineering the third wave of biocatalysis
2012 StandoutNature
[27] Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy
1978
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
1987 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The Hutchinson-Gilford progeria syndrome
1972
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Fifty years of amanitin
1991
Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo.
1980 StandoutNobel
Demonstration of low density lipoprotein receptors in mouse teratocarcinoma stem cells and description of a method for producing receptor-deficient mutant mice
1979 StandoutNobel
Structural basis of transcription: α-Amanitin–RNA polymerase II cocrystal at 2.8 Å resolution
2002 StandoutNobel
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Premenopausal castration and documented coronary atherosclerosis
1971
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
The kinetic characteristics of inhibition of hepatic cholesterogenesis by lipoproteins of intestinal origin
1975
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
High density lipoprotein as a protective factor against coronary heart disease
1977 Standout
Mutant clone of Chinese hamster ovary cells lacking 3-hydroxy-3 -methylglutaryl coenzyme A reductase.
1983 StandoutNobel
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.
1989
Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.
1975 StandoutNobel
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells.
1977
Intracellular phospholipases A
1980
Age trend of mortality from coronary artery disease in women and observations on the reproductive patterns of those affected
1964
Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat.
1976 StandoutNobel
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Solubilization and Purification of trans-Farnesyl Pyrophosphate-Squalene Synthetase
1971
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Chromatographic separation of serum lipoproteins on glass powder columns
1960
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle.
1978 StandoutNobel
Antibody against low density lipoprotein receptor blocks uptake of low density lipoprotein (but not high density lipoprotein) by the adrenal gland of the mouse in vivo.
1981 StandoutNobel
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.
1994
Acute in vivo effects of HCG and LH on ovarian mitochondrial cholesterol utilization
1975
The Clearing Factor Lipase and Its Action in the Transport of Fatty Acids between the Blood and the Tissues
1963
Myocardial infarction in young women
1976
Estrogen and Coronary Heart Disease in Women
1991 Standout
Regulation of Cholesterol Metabolism
1970
Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities.
1977
Physical-Chemical Basis of Lipid Deposition in Atherosclerosis
1974 Science
Lipolytic Activity of Post-Heparin Plasma in Hyperlipemia and Hypolipemia
1965
Assembly of the 26 S complex that degrades proteins ligated to ubiquitin is accompanied by the formation of ATPase activity.
1990 StandoutNobel
Serum Lipids in Men with Myocardial Infarction
1960
Squalene synthetase activity in human fibroblasts: Regulation via the low density lipoprotein receptor
1979 StandoutNobel
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe.
1983 StandoutNobel
Pentalenolactone Biosynthesis. Molecular Cloning and Assignment of Biochemical Function to PtlI, a Cytochrome P450 of Streptomyces avermitilis
2006 StandoutNobel
Regulation of Cholesterol Metabolism
1970
Inhibition by Carbon Monoxide of the Secondary‐Amine Mono‐oxygenase of Pseudomonas aminovorans and the Photochemical Action Spectrum for Its Reversal
1975
Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat
2015 StandoutNobel
Chemical mechanisms for cytochrome P-450 oxidation: spectral and catalytic properties of a manganese-substituted protein.
1982
MYOCARDIAL INFARCTION IN WOMEN
1955
Separate mechanisms for the uptake of high and low density lipoproteins by mouse adrenal gland in vivo.
1979 StandoutNobel
Myocardial Infarction and Estrogen Therapy in Post-Menopausal Women
1976
Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma
1955
Heme-Containing Oxygenases
1996 Standout
The Pathogenesis of Atherosclerosis
1976 Standout
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
Studies on the distribution of tocopherol in human serum lipoproteins
1960
ATP-dependent protease in bovine adrenal cortex. Tissue specificity, subcellular localization, and partial characterization.
1985
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis
1967
Cytochrome P-450scc-substrate interactions. Studies of binding and catalytic activity using hydroxycholesterols.
1982
SERUM LIPIDS AND LIPOPROTEINS DURING LONG-TERM ADMINISTRATION OF AN ORAL CONTRACEPTIVE
1966
Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase
1978 StandoutNobel
Estrogen use and myocardial infarction risk: A case-control study
1984
High levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in the ovary of the pregnant rabbit.
1978 StandoutNobel
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years
1975
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat.
1977 StandoutNobel
Menopause and the Risk of Coronary Heart Disease in Women
1987
Cytochrome P450 and biological hydroxylation reactions
2005
Gonadal Function and the Development of Coronary Heart Disease
1963
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Menopause and Risk of Cardiovascular Disease
1976 Standout
Ischaemic Heart Disease in Young Women
1974

Works of G.S. Boyd being referenced

Separation of two forms of cytochrome P450 adrenal cortex mitochondria
1970
Oxidation of cholesterol and cholesterol analogues by mitochondrial preparations of steroid-hormone-producing tissue
1976
SERUM LIPOPROTEIN PATTERNS IN CORONARY SCLEROSIS AND ASSOCIATED CONDITIONS
1955
THE PLASMA LIPIDS IN CORONARY ARTERY DISEASE
1953
The role of cholesterol and cytochrome P-450 in the cholesterol side chain cleavage reaction in adrenal cortex and corpora lutea
1975
Bile acids in the rat: studies in experimental occlusion of the bile duct
1966
Cytochrome P-450 in steroid biogenesis
1969
Partial resolution of the mixed-function oxidase involved in the cholesterol side-chain cleavage reaction in bovine adrenal mitochondria
1967
THYROID HORMONES AND PLASMA LIPIDS
1960
ENDOCRINE ASPECTS OF CORONARY SCLEROSIS
1956
Acth activation of cytosol triglyceride hydrolase in the adrenal of the rat
1977
Biochemistry, Biophysics and Regulation of Cytochrome P-450
1981
The Cholesterol Side-Chain Cleavage System of Bovine Adrenal Cortex
1967
Cholesterol Metabolism and Steroid-Hormone Production
1978
The effect of estrogens on the plasma lipids in coronary artery disease
1954
EFFECT OF BILATERAL OVARIECTOMY ON CORONARY-ARTERY DISEASE AND SERUM-LIPID LEVELS
1959
Plasma lipid and serum lipoprotein patterns during pregnancy and puerperium.
1955
Accumulation of Squalene during Hepatic Cholesterol Synthesis in vitro
1970
The estimation of serum lipoproteins. A micromethod based on zone electrophoresis and cholesterol estimations
1954
The cholesterol side-chain cleavage system of the adrenal cortex: A mixed-function oxidase
1966
THE EFFECT OF CERTAIN THYROXINE ANALOGUES ON THE SERUM LIPIDS IN HUMAN SUBJECTS
1960
THE DETECTION OF DIFFERENT STATES OF THE P‐450 CYTOCHROMES IN ADRENAL MITOCHONDRIA; CHANGES INDUCED BY ACTH
1973
The clearing by heparin of alimentary lipaemia in coronary artery disease.
1953
Progeria and Atherosclerosis
1955
CHOLESTEROL METABOLISM IN THE ADRENAL CORTEX: STUDIES ON THE MODE OF ACTION OF ACTH*
1973
The Influence of the Sex Hormones on the Circulating Lipids and Lipoproteins in Coronary Sclerosis
1956
Rankless by CCL
2026